Next Gen Diagnostics Showcases Automated Genomic Sequencing Service

The new NGD System automates sample prep and bioinformatics to provide actionable reports for infection control teams.

Apr. 1, 2026 at 6:13am

Got story updates? Submit your updates here. ›

Next Gen Diagnostics (NGD), a biotechnology company based in Cambridge, Massachusetts, will showcase its new NGD System at the SHEA Spring conference. The NGD System automates both sample preparation and bioinformatics, generating actionable reports for Infection Prevention teams to help detect and track disease transmission.

Why it matters

Whole genome sequencing (WGS) is a powerful tool for infection control, but has traditionally been complex and labor-intensive. The NGD System aims to make WGS-based transmission detection more accessible and scalable for healthcare facilities.

The details

The NGD System automates the entire WGS workflow, from sample preparation to bioinformatics analysis. This allows Infection Prevention teams to quickly identify transmission events and implement targeted interventions without the need for specialized genomics expertise.

  • Next Gen Diagnostics will showcase the NGD System at the SHEA Spring conference on April 1, 2026.

The players

Next Gen Diagnostics

A biotechnology company based in Cambridge, Massachusetts that develops automated genomic sequencing solutions for infection control.

Got photos? Submit your photos here. ›

What’s next

Next Gen Diagnostics will demonstrate the NGD System at Booth #14 during the SHEA Spring conference, where they will showcase the system's capabilities to Infection Prevention professionals.

The takeaway

The NGD System represents a significant advancement in making whole genome sequencing more accessible and scalable for healthcare facilities, empowering Infection Prevention teams to rapidly detect and respond to disease transmission events.